UK & AU Stock Market Today: Live Updates 27.04.2026
LIVEMarkets rolling coverageStarted: April 27, 2026, 12:00 AM EDTUpdated: April 27, 2026, 11:58 PM EDT EVE Health Names Ben Rohr as CEO to Drive Commercial Growth April 27, 2026, 11:58 PM EDT. EVE Health Group (ASX: EVE) has appointed Ben Rohr as CEO, effective immediately, signaling a shift to accelerate commercialisation. Rohr, previously COO, has led key initiatives including the $3 million Nextract acquisition and product integration. He will focus on expanding EVE's reformulated pharmaceutical compounds, specializing in enhanced delivery systems for drugs nearing patent expiry. Current CEO Damian Wood transitions to head regulatory and medical affairs, overseeing clinical development.